Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incannex Healthcare (IXHL) Share-based Compensation (2023 - 2025)

Historic Share-based Compensation for Incannex Healthcare (IXHL) over the last 3 years, with Q4 2025 value amounting to -$2.3 million.

  • Incannex Healthcare's Share-based Compensation fell 42390.8% to -$2.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.1 million, marking a year-over-year decrease of 6241.11%. This contributed to the annual value of $2.6 million for FY2025, which is 7077.73% down from last year.
  • According to the latest figures from Q4 2025, Incannex Healthcare's Share-based Compensation is -$2.3 million, which was down 42390.8% from $2.6 million recorded in Q3 2025.
  • Incannex Healthcare's 5-year Share-based Compensation high stood at $3.4 million for Q4 2023, and its period low was -$2.3 million during Q4 2025.
  • Over the past 3 years, Incannex Healthcare's median Share-based Compensation value was $878500.0 (recorded in 2024), while the average stood at $1.1 million.
  • Examining YoY changes over the last 5 years, Incannex Healthcare's Share-based Compensation showed a top increase of 47211.33% in 2025 and a maximum decrease of 42390.8% in 2025.
  • Over the past 3 years, Incannex Healthcare's Share-based Compensation (Quarter) stood at $3.4 million in 2023, then tumbled by 112.81% to -$435000.0 in 2024, then plummeted by 423.91% to -$2.3 million in 2025.
  • Its last three reported values are -$2.3 million in Q4 2025, $2.6 million for Q3 2025, and $1.3 million during Q2 2025.